The neuroinflammatory response during the course of Alzheimer's disease (AD) is triggered by the deposition of the β-amyloid peptide in extracellular plaques and ongoing neurodegeneration. This evidence concerns the gene PPIB and early-onset autosomal dominant Alzheimer disease.